Message Board

Respected readers, authors and reviewers, you can add comments to this page on any questions about the contribution, review,        editing and publication of this journal. We will give you an answer as soon as possible. Thank you for your support!

Name
E-mail
Phone
Title
Content
Verification Code

Jing Li, Zeng Renjie, Sun Weizhang, Liu Qing. Study on the dissolution of mitoxantrone in mitoxantron-hydroxylapatite ceramic composites in vitro[J]. Journal of Pharmaceutical Practice and Service, 1999, (5): 298-299.
Citation: Jing Li, Zeng Renjie, Sun Weizhang, Liu Qing. Study on the dissolution of mitoxantrone in mitoxantron-hydroxylapatite ceramic composites in vitro[J]. Journal of Pharmaceutical Practice and Service, 1999, (5): 298-299.

Study on the dissolution of mitoxantrone in mitoxantron-hydroxylapatite ceramic composites in vitro

  • Received Date: 1999-02-01
  • OBJECTIVE To investigate the drug-releasing regularity in vitro of variable concentration mitoxantrone,which wax in a matoxantrone hydroxylapatite ceramic composite encapsulated with wax (DHAQ-PHA-WAX) and DHAQ-PHA without the wax.hydroxylapatite ceramic was used as drug carrier and wax as inhibitor. METHODS The released drug concentration per-day was determined by visible spectrometry at λ =660nm. RESULTS There was a significant difference (P<0.05) between DHAQ-PHA dissolution velocity and DHAQ-PHA-WAX. CONCLUTION Releasing of DHAQ could be controlled with DHAQ-PHA-WAX.
  • 加载中
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Article Metrics

Article views(2236) PDF downloads(776) Cited by()

Related
Proportional views

Study on the dissolution of mitoxantrone in mitoxantron-hydroxylapatite ceramic composites in vitro

Abstract: OBJECTIVE To investigate the drug-releasing regularity in vitro of variable concentration mitoxantrone,which wax in a matoxantrone hydroxylapatite ceramic composite encapsulated with wax (DHAQ-PHA-WAX) and DHAQ-PHA without the wax.hydroxylapatite ceramic was used as drug carrier and wax as inhibitor. METHODS The released drug concentration per-day was determined by visible spectrometry at λ =660nm. RESULTS There was a significant difference (P<0.05) between DHAQ-PHA dissolution velocity and DHAQ-PHA-WAX. CONCLUTION Releasing of DHAQ could be controlled with DHAQ-PHA-WAX.

Jing Li, Zeng Renjie, Sun Weizhang, Liu Qing. Study on the dissolution of mitoxantrone in mitoxantron-hydroxylapatite ceramic composites in vitro[J]. Journal of Pharmaceutical Practice and Service, 1999, (5): 298-299.
Citation: Jing Li, Zeng Renjie, Sun Weizhang, Liu Qing. Study on the dissolution of mitoxantrone in mitoxantron-hydroxylapatite ceramic composites in vitro[J]. Journal of Pharmaceutical Practice and Service, 1999, (5): 298-299.

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return